Alpha-fluoromethylhistidine, an Inhibitor of Histamine Biosynthesis, Causes Arterial Hypertension

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1996 Nov 1

PMID 8938662

Citations 1

Authors

H A CAMPOS

Y Acuna

L Magaldi

A Israel

Affiliations

Soon will be listed here.

Abstract

In this study we assessed the cardiovascular response to 13 days of irreversible inhibition of the enzyme histidine-decarboxylase (HD) with alpha-fluoro-methylhistidine (AFMH). Age-matched untreated rats were used as controls, Tail-cuff mean arterial pressure (MAP) and heart rate (HR) rose progressively in AFMH-treated rats, reaching maximal values during the study period by the 13th day of treatment. There was a reduction in urinary histamine at the day 7 and 13, and of sodium excretion at the day 7 of treatment, while the renal catecholamine excretion was increased at both days of treatment, suggesting an increase of sympathetic activity. At the 13th day of treatment, there was an activation of the renin-angiotensin-aldosterone system. In addition, the cardiovascular responses to footshock stress were determined in rats treated intraperitoneally (i.p.) or intracerebroventricularly (i.v.t.) with a single dose of AFMH. Peripheral sympathetic facilitation was found, as the hemodynamic response to footshock stress was significantly enhanced after i.p. administration, but not after i.v.t. administration of AFMH. Our results suggest that conditions of peripheral histamine deficiency may result in sympathetic facilitation, arterial hypertension and tachycardia in the rat.

Citing Articles

Central endogenous histamine modulates sympathetic outflow through H3 receptors in the conscious rabbit.

Charles J, Angus J, Wright C Br J Pharmacol. 2003; 139(5):1023-31.

PMID: 12839877 PMC: 1573916. DOI: 10.1038/sj.bjp.0705322.

References

Akins V, Bealer S . Central nervous system histamine regulates peripheral sympathetic activity. Am J Physiol. 1991; 260(1 Pt 2):H218-24. DOI: 10.1152/ajpheart.1991.260.1.H218. View

Panula P, Kaartinen M, MacKlin M, Costa E . Histamine-containing peripheral neuronal and endocrine systems. J Histochem Cytochem. 1985; 33(9):933-41. DOI: 10.1177/33.9.3894504. View

Maeyama K, Watanabe T, Yamatodani A, Taguchi Y, Kambe H, Wada H . Effect of alpha-fluoromethylhistidine on the histamine content of the brain of W/Wv mice devoid of mast cells: turnover of brain histamine. J Neurochem. 1983; 41(1):128-34. DOI: 10.1111/j.1471-4159.1983.tb11823.x. View

Slotkin T, Bartolome J, Whitmore W . Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines. Life Sci. 1983; 33(21):2137-45. DOI: 10.1016/0024-3205(83)90338-7. View

Ishikawa S, Sperelakis N . A novel class (H3) of histamine receptors on perivascular nerve terminals. Nature. 1987; 327(6118):158-60. DOI: 10.1038/327158a0. View

Soe-Jensen P, Knigge U, Garbarg M, Kjaer A, Rouleau A, Bach F . Responses of anterior pituitary hormones and hypothalamic histamine to blockade of histamine synthesis and to selective activation or inactivation of presynaptic histamine H3 receptors in stressed rats. Neuroendocrinology. 1993; 57(3):532-40. DOI: 10.1159/000126402. View

Laverty R, Taylor K . The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal Biochem. 1968; 22(2):269-79. DOI: 10.1016/0003-2697(68)90316-3. View

Johnson H, BEAVEN M, Erjavec F, Brodie B . Selective labeling and release of nonmast-cell histamine. Life Sci. 1966; 5(2):115-23. DOI: 10.1016/0024-3205(66)90122-6. View

KOLLONITSCH J, Perkins L, PATCHETT A, Doldouras G, Marburg S, DUGGAN D . Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature. 1978; 274(5674):906-8. DOI: 10.1038/274906a0. View

10.

Israel A, Barbella Y, Saavedra J . Compensatory increase in adrenomedullary angiotensin-converting enzyme activity (kininase II) after unilateral adrenalectomy. Regul Pept. 1986; 16(2):97-105. DOI: 10.1016/0167-0115(86)90053-4. View

11.

Schwartz J, Arrang J, Garbarg M, Pollard H, Ruat M . Histaminergic transmission in the mammalian brain. Physiol Rev. 1991; 71(1):1-51. DOI: 10.1152/physrev.1991.71.1.1. View

12.

Arrang J, Garbarg M, Schwartz J . Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 1983; 302(5911):832-7. DOI: 10.1038/302832a0. View

13.

CAMPOS H, Briceno E . Two models of peripheral sympathetic autoregulation: role of neuronal histamine. J Pharmacol Exp Ther. 1992; 261(3):943-50. View

14.

Severs W, Taylor J, Connor J . A central effect of angiotensin: release of pituitary pressor material. J Pharmacol Exp Ther. 1970; 174(1):27-34. View

15.

Prast H . Inhibition of histamine synthesis influences the development of hypertension in spontaneously hypertensive rats. Agents Actions. 1991; 33(1-2):126-8. DOI: 10.1007/BF01993145. View

16.

Hey J, del Prado M, Egan R, Kreutner W, Chapman R . Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors. Br J Pharmacol. 1992; 107(2):347-51. PMC: 1907887. DOI: 10.1111/j.1476-5381.1992.tb12749.x. View

17.

Arrang J, Devaux B, Chodkiewicz J, Schwartz J . H3-receptors control histamine release in human brain. J Neurochem. 1988; 51(1):105-8. DOI: 10.1111/j.1471-4159.1988.tb04841.x. View

18.

Hakanson R . Kinetic properties of mammalian histidine decarboxylase. Eur J Pharmacol. 1967; 1(1):42-6. DOI: 10.1016/0014-2999(67)90064-7. View

19.

Itoh Y, Oishi R, Nishibori M, Saeki K . Histamine turnover in the rat hypothalamic nuclei estimated from alpha-fluoromethylhistidine-induced histamine decrease. Jpn J Pharmacol. 1989; 51(4):581-4. DOI: 10.1254/jjp.51.581. View

20.

Yoshitomi I, Oishi R, Itoh Y, Saeki K, Senoo Y, Teramoto S . alpha-Fluoromethylhistidine decreases the histamine content of the rat right atrium under the influence of sympathetic activity. Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(5):528-32. DOI: 10.1007/BF00167256. View